Soleus Capital Initiates Discussions with Board and Management of Theratechnologies (THTX) on Value Enhancement Strategies

Jul 05, 2024

∙ Paid

Key Summary: On November 28, 2023, Soleus Capital (10.5%) communicated with the Board and management about enhancing stockholder value, including the potential appointment of a designated candidate to the Board and engaging an investment bank for strategic transactions.

Market Cap: $104 million | Theratechnologies Inc., a biopharmaceutical company, focus…

This post is for paid subscribers

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts

Snowball Research

Soleus Capital Initiates Discussions with Board and Management of Theratechnologies (THTX) on Value Enhancement Strategies

This post is for paid subscribers